Andreas Goutopoulos, Actithera CEO
July 9, 2025 03:00 AM EDTUpdated 06:20 AM
Financing
Startups
Manufacturing

Nim­ble ra­dio­phar­ma biotech Ac­tithera gets $75M to en­ter the clin­ic

Kyle LaHucik

Biotech Correspondent

For a year and a half, Ac­tithera was es­sen­tial­ly a one-man show.

As the ra­dio­phar­ma start­up’s on­ly em­ploy­ee, CEO An­dreas Goutopou­los had to hus­tle for …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Bio­phar­ma's 20 high­est-paid CEOs of 2024 with $20M+ pay­days

Trump hints at tar­iff grace pe­ri­od for phar­ma com­pa­nies to bring man­u­fac­tur­ing to US

Mer­ck drops $10B for res­pi­ra­to­ry drug­mak­er Verona Phar­ma in its first ac­qui­si­tion of 2025

In first half of 2025, nov­el drug ap­provals are in line with pre­vi­ous years

Ex­clu­sive: Start­up rais­es $45M for uni­ver­sal flu vac­cines made with mR­NA

sponsored

Un­cov­er­ing the Po­ten­tial of Tar­get­ing the CD38 Path­way for Im­mune-Me­di­at­ed Dis­eases

A service from the Financial Times